The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during the forecast period, according to a new report by ...

21 June 2022 Ohio-based Cleveland Medical Devices (CleveMed) has accused ResMed of infringing patents through the sale of ...

Shares of ResMed Inc. RMD rose 1.46% to $239.95 Friday, on what proved to be an all-around positive trading session for the ...

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience ...

Resmed has acquired VirtuOx, a Coral Springs, Fla.-based IDTF, to address a bottleneck in sleep apnea testing that is creating "one of the biggest barriers" to CPAP therapy, says Resmed Chief ...

The deal is set to enhance Resmed's ability to collaborate with healthcare providers to improve the diagnostic process.

Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

ResMed (RMD) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.13 per share a year ago. These figures are ...

But it’s a combination you’ll want to be aware of if you use a CPAP to help improve your nighttime sleep. A continuous positive airway pressure (CPAP) machine is a device frequently prescribed ...

In this role, Schwartz will lead Resmed's global investor relations function and report to Mick Farrell, Chairman of the Board and CEO. Schwartz is a seasoned executive with more than two decades ...